{"nctId":"NCT00328770","briefTitle":"De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma","startDateStruct":{"date":"1996-12"},"conditions":["Liver Carcinoma"],"count":70,"armGroups":[{"label":"Sirolimus based immunosuppression","type":"EXPERIMENTAL","interventionNames":["Drug: Sirolimus"]}],"interventions":[{"name":"Sirolimus","otherNames":["Rapamune"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult patients with hepatocellular (HCC) carcinoma receiving liver transplant\n\nExclusion criteria:\n\n* Patients less than 18 years of age","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants Surviving at One and Four Years After Liver Transplant","description":"Percent of Patients Surviving at One \\& Four years after Liver Transplant was calculated","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"85","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77","spread":null}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants Surviving With no Evidence of Recurrent Tumor at One and Four Years After Liver Transplant","description":"Percentage of Participants Surviving with no Evidence of Recurrent Hepatocellular Carcinoma at One and Four Years After Liver Transplant","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"74","spread":null}]}]}]},{"type":"SECONDARY","title":"Sirolimus Toxicity/Intolerance","description":"Sirolimus toxicity/intolerance requiring discontinuation of sirolimus","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":70},"commonTop":["Other unspecified reasons for discontinuation of sirolimus","Mouth ulcers","Dyslipidemia"]}}}